Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Microwave‐assisted Synthesis of Hybrid Heterocyclics as Biological Potent Molecules

Microwave‐assisted Synthesis of Hybrid Heterocyclics as Biological Potent Molecules A series of novel 5‐((1H‐benzo[d]imidazol‐2‐yl)methyl)‐2‐((3aR,5S,6S,6aR)‐2,2‐dimethyl‐6‐((1‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)methoxy)tetrahydrofuro[2,3‐d][1,3]dioxol‐5‐yl)‐3‐phenylthiazolidin‐4‐ones 9a–n has been synthesized from triazole‐linked thiazolidinone derivatives 8a–g with o‐phenylenediamine and characterized by IR, NMR, MS, and elemental analyses. Further, these compounds were screened for their antibacterial activity against Gram‐positive bacteria, namely, Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538p), and Micrococcus luteus (IFC 12708), and Gram‐negative bacteria, namely, Proteus vulgaris (ATCC 3851), Salmonella typhimurium (ATCC 14028), and Escherichia coli (ATCC 25922). Among the screened compounds, compounds 9b, 9d, 9h, and 9i are highly active against almost all selected bacterial strains; the remaining compounds showed moderate to good activity and emerged as potential molecules for further development. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Heterocyclic Chemistry Wiley

Microwave‐assisted Synthesis of Hybrid Heterocyclics as Biological Potent Molecules

Loading next page...
 
/lp/wiley/microwave-assisted-synthesis-of-hybrid-heterocyclics-as-biological-gTU0Lpz7oj

References (61)

Publisher
Wiley
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0022-152X
eISSN
1943-5193
DOI
10.1002/jhet.3187
Publisher site
See Article on Publisher Site

Abstract

A series of novel 5‐((1H‐benzo[d]imidazol‐2‐yl)methyl)‐2‐((3aR,5S,6S,6aR)‐2,2‐dimethyl‐6‐((1‐phenyl‐1H‐1,2,3‐triazol‐4‐yl)methoxy)tetrahydrofuro[2,3‐d][1,3]dioxol‐5‐yl)‐3‐phenylthiazolidin‐4‐ones 9a–n has been synthesized from triazole‐linked thiazolidinone derivatives 8a–g with o‐phenylenediamine and characterized by IR, NMR, MS, and elemental analyses. Further, these compounds were screened for their antibacterial activity against Gram‐positive bacteria, namely, Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 6538p), and Micrococcus luteus (IFC 12708), and Gram‐negative bacteria, namely, Proteus vulgaris (ATCC 3851), Salmonella typhimurium (ATCC 14028), and Escherichia coli (ATCC 25922). Among the screened compounds, compounds 9b, 9d, 9h, and 9i are highly active against almost all selected bacterial strains; the remaining compounds showed moderate to good activity and emerged as potential molecules for further development.

Journal

Journal of Heterocyclic ChemistryWiley

Published: Jan 1, 2018

There are no references for this article.